内科学（第二）講座

Keyphrases

1. Ablation 5%
2. Acute Decompensated Heart Failure 30%
3. Adaptive Servo-ventilation 11%
4. Adverse Events 6%
5. All-cause Mortality 10%
6. Aortic Insufficiency 8%
7. Arginine Vasopressin 5%
8. Atrial Fibrillation 21%
9. B-type Natriuretic Peptide 11%
10. Beta-blockers 10%
11. Bosentan 5%
12. Cardiac Function 6%
13. Cardiac Output 5%
14. Cardiac Resynchronization Therapy 8%
15. Cardiogenic Shock 8%
16. Cardiovascular Mortality 9%
17. Catheter 6%
18. Catheter Ablation 10%
19. Chronic Heart Failure 5%
20. Chronic Kidney Disease 8%
21. Clinical Outcomes 21%
22. Combination Therapy 6%
23. Confidence Interval 16%
24. Congestive Heart Failure 11%
25. Consecutive Patients 5%
26. Continuous-flow Left Ventricular Assist Device (CF-LVAD) 11%
27. Device Implantation 10%
28. Everolimus 5%
29. Hazard Ratio 11%
30. Heart Failure 33%
31. Heart Failure Hospitalization 8%
32. Heart Failure Patients 20%
33. Heart Failure Readmission 5%
34. Heart Failure with Preserved Ejection Fraction (HFpEF) 10%
35. Heart Rate 17%
36. Heart Transplantation 19%
37. Hyperkalemia 5%
38. Hyponatremia 5%
39. Impella 12%
40. Implantable Left Ventricular Assist Device 5%
41. Ivabradine 5%
42. Japan 25%
43. Japanese Patients 11%
44. Left Ventricular Assist Device 51%
45. Left Ventricular Assist Device Implantation 30%
46. Left Ventricular Assist Device Support 13%
47. Left Ventricular Assist Device Therapy 5%
48. Left Ventricular Dysfunction 6%
49. Left Ventricular Ejection Fraction 12%
50. Left Ventricular Function 7%
51. Left Ventricular Remodeling 7%
52. Lung Fluid 5%
53. MitraClip 5%
54. Mitral Regurgitation 5%
55. Multicenter Registry 5%
56. Muscle Sympathetic Nerve Activity 7%
57. Myocytes 5%
58. Non-valvular Atrial Fibrillation 6%
59. Odds Ratio 6%
60. Older Men 6%
61. Paroxysmal Atrial Fibrillation 6%
62. Patients with Chronic Heart Failure 10%
63. Patients with Heart Failure 35%
64. Poor Prognosis 5%
65. Prognostic Impact 12%
66. Pulmonary Arterial Hypertension 8%
67. Pulmonary Capillary Wedge Pressure 9%
68. Pulmonary Congestion 5%
69. Pulmonary Vascular Resistance 5%
70. Quality of Life 6%
71. Ramp Test 5%
72. Remote Dielectric Sensing 12%
73. Right Heart Catheterization 5%
74. Right Ventricular Function 6%
75. Risk Stratification 5%
76. Severe Aortic Stenosis 10%
77. Sodium Zirconium Cyclosilicate 5%
78. Sodium-glucose Cotransporter 2 Inhibitors (SGLT2i) 5%
79. Stage D Heart Failure 7%
80. Sympathetic Nerve Activity 7%
81. Systolic Heart Failure 7%
82. Therapeutic Strategies 9%
83. Tolvaptan 28%
84. Transcatheter Aortic Valve Implantation 26%
85. Transcatheter Aortic Valve Replacement 41%
86. Transesophageal Echocardiography 5%
87. Valvular Interventions 7%
88. Ventilation Therapy 5%
89. Ventricular Arrhythmia 5%
90. Ventricular Assist Device 15%
91. Ventricular Fibrillation 5%
92. Ventricular Myocytes 6%
93. Waon Therapy 5%

Medicine and Dentistry

1. Ablation 11%
2. Acute Decompensated Heart Failure 5%
3. Adverse Event 10%
4. All Cause Mortality 7%
5. Aortic Insufficiency 10%
6. Aortic Stenosis 15%
7. Aortic Valve 5%
8. Apoplexy 8%
9. Assisted Circulation 9%
10. Atrial Fibrillation 24%
11. Beta Adrenergic Receptor Blocking Agent 6%
12. Bleeding 5%
13. Brain Natriuretic Peptide 16%
14. Cannula 5%
15. Cardiac Catheterization 6%
16. Cardiac Resynchronization Therapy 9%
17. Cardiogenic Shock 8%
18. Cardiovascular System 11%
19. Chronic Kidney Disease 7%
20. Combination Therapy 11%
21. Congestive Heart Failure 100%
22. Device Therapy 6%
23. Dilated Cardiomyopathy 6%
24. Drug Therapy 5%
25. Ejection Fraction 8%
26. Elderly Patient 5%
27. Hazard Ratio 15%
28. Heart Failure with Preserved Ejection Fraction 5%
29. Heart Function 8%
30. Heart Graft 5%
31. Heart Left Ventricle Ejection Fraction 14%
32. Heart Output 5%
33. Heart Transplantation 21%
34. Hemodynamic 29%
35. Ivabradine 5%
36. Kidney Function 5%
37. Left Ventricle 5%
38. Left Ventricular Assist Device 81%
39. Lung Congestion 6%
40. Lung Fluid 5%
41. Mitral Insufficiency 12%
42. Nerve Conduction 9%
43. New York Heart Association Class 5%
44. Odds Ratio 8%
45. Paroxysmal Atrial Fibrillation 6%
46. Percutaneous Aortic Valve Replacement 71%
47. Pulmonary Artery 6%
48. Pulmonary Artery Occlusion Pressure 8%
49. Pulmonary Hypertension 8%
50. Quality of Life 6%
51. Recurrent Disease 7%
52. Scoring System 6%
53. Sympathetic Nerve 8%
54. Systolic Heart Failure 6%
55. Thromboembolism 5%
56. Tolvaptan 12%
57. Valvular Intervention 8%
58. Ventricular Assist Device 21%
59. Ventricular Fibrillation 5%
60. Ventricular Tachycardia 5%